{
    "organizations": [],
    "uuid": "0898b472a371f40c5c4257380c3bc9bfa483c16a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-iovance-biotherapeutics-intends-to/brief-iovance-biotherapeutics-intends-to-offer-and-sell-125-mln-of-its-common-stock-idUSASB0C26P",
    "ord_in_thread": 0,
    "title": "BRIEF-Iovance Biotherapeutics‍ Intends To Offer And Sell $125 Mln Of Its Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 14 PM / in 6 minutes BRIEF-Iovance Biotherapeutics‍ Intends To Offer And Sell $125 Mln Of Its Common Stock Reuters Staff \nJan 24 (Reuters) - Iovance Biotherapeutics Inc: \n* IOVANCE BIOTHERAPEUTICS, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK \n* IOVANCE BIOTHERAPEUTICS INC - ‍INTENDS TO OFFER AND SELL $125 MILLION OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING​ \n* IOVANCE BIOTHERAPEUTICS INC - ‍INTENDS TO USE PROCEEDS FROM OFFERING TO FUND ITS ONGOING CLINICAL TRIALS FOR ITS CURRENT PRODUCT CANDIDATES​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-24T23:11:00.000+02:00",
    "crawled": "2018-01-24T23:28:44.047+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "intends",
        "offer",
        "sell",
        "mln",
        "common",
        "stock",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "iovance",
        "biotherapeutics",
        "inc",
        "iovance",
        "biotherapeutics",
        "announces",
        "public",
        "offering",
        "common",
        "stock",
        "iovance",
        "biotherapeutics",
        "inc",
        "offer",
        "sell",
        "million",
        "common",
        "stock",
        "underwritten",
        "public",
        "iovance",
        "biotherapeutics",
        "inc",
        "use",
        "proceeds",
        "offering",
        "fund",
        "ongoing",
        "clinical",
        "trial",
        "current",
        "product",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}